STOCKS TELEGRAPH

Author: ST Staff

  • Is This Why The KUYAF Stock Fell In Last Trading?

    The price of Kuya Silver Corporation (OTCQB: KUYAF) stock dropped -4.70% to $1.5562 in the last trading session. Kuya’s stock price fluctuated between $1.5452 and $1.7780 during the session, with 192.39K shares changing hands. A private placement announced last month likely to close next week is likely to be ending in negative territory for the KUYAF stock.

    Which private placement was it?

    Kuya is a Canadian silver-focused mining company with operations in Central Peru. KUYAF owns the Bethania Project, which includes the Bethania mine. To restart operations, KUYAF intends to implement an expansion at the Bethania mine and build a concentrator plant for toll-milling its ore.

    The mine was in production until 2016, toll-milling its ore at various concentrate plants around the region. Due to market conditions and insufficient working capital, the Bethania mine was placed on care and maintenance after it produced silver-lead and zinc concentrates from run-of-mine material.

    Late last month, Kuya announced that it entered into a term sheet with Cormark Securities.

    • Under the agreement, Cormark Securities will buy 4,211,000 units of KUYAF at $1.90 each.
    • As a result, KUYAF received approximately $8 million in aggregate gross proceeds from that private placement.
    • A portion of the Units of the Offering may also be acquired by the Underwriters at any time up to the closing of the Offering at a price not exceeding 15%.
    • There will be one KUYAF common share and half a warrant for every Unit.
    • Following the closing of the Offering, KUYAF’s holders will be able to acquire one Common Share for $2.60 at the exercise price for 24 months following the date of closing.

    What will KUYAF do with it?

    KUYAF anticipates closing the Offering on or about June 16, 2021, pending certain conditions, including regulatory approval, including approval by the Canadian Securities Exchange. Kuya (KUYAF) intends to use the net proceeds of the Offering to finance development and working capital activities at the Bethania project.

  • Is EVmo (YAYO) Stock Price Up This Past Session?

    A recent close of $2.1200 in EVmo Inc (OTCPk: YAYO)’s stock showed an unexpected 5.21% rise. In the past week, EVmo stock gained 3.41%, compared with a monthly gain of -29.53%. While YAYO stock increased without any current news, the company recently released its financial results, which may provide additional information.

    What was YAYO’s performance like?

    EVmo Inc. was previously known as YayYo Inc. YAYO links rideshare, delivery and logistics companies, as well as the customers of drivers, with companies in the rideshare, delivery and logistics business that need drivers to operate. In this ever-expanding gig economy, Yayo is a leading provider of rental vehicles to drivers and delivery companies. Innovative policy and program initiatives make YAYO unique by supporting drivers from both very high and very low income levels.

    EVmo, which provides vehicles for the rideshare and delivery gig economy industries, recently announced financial results for the first quarter ended March 31, 2021.

    First Quarter 2021 Highlights:

    • For the Q1, 2021, YAYO recorded revenue of $2.3M which was up 31.3% over Q1 2020 revenue of $1.7M.
    • Gross profit reported by YAYO in the reported quarter was 57% higher than Q1 2020.
    • A company-operated maintenance facility has also been introduced by Yayo.
    • This facility will lower maintenance costs and enable a quicker return to service.
    • In the reported quarter, YAYO received electric vehicles (EVs) from Tesla and Hyundai.
    • Managed fleet at YAYO is now 14 percent electric, and is expected to continue growing in that direction through 2021.

    Did YAYO accomplish anything else during this reported quarter?

    To accommodate its accelerated growth, EVmo (YAYO) moved headquarters into a larger and more impressive facility. YAYO entered the last-mile logistics space, deploying cargo vans with high roofs. YAYO also came restructuring a $5M credit line to meet increased demand.

  • Altium (ALMFF) Stock Rose 37%. How Did That Happen?

    The stock of Altium Ltd [OTCPINK: ALMFF] bounded at the previous close, surging 37.41% to $29.640. Volume on Altium stock was 3.87K against an average volume of 938 over the past 30 days. The value of ALMFF stock during the last 52 weeks ranged from $18.720 to $30.380. ALMFF stock soared upon learning of the takeover bid.

    An acquisition bid for ALMFF was made by who?

    Altium is a global software company with its headquarters in San Diego, California. Through electronic innovation, the ALMFF accelerates technology advancement. Altium is known for creating software that maximizes engineers’ and PCB designers’ productivity for over 30 years. ALMFF software is used to design and realize electronic products worldwide by more designers and engineers, from individual inventors to multinational corporations.

    In a statement released on Monday, Autodesk confirmed that it has proposed a non-binding scheme of arrangement for the acquisition of all outstanding common stock of Altium Limited for AUD$38.50.

    With ALMFF’s solutions, Autodesk would be able to deliver significant, certain, and immediate value to its shareholders while enabling customers unique opportunities. On June 4, 2021, one business day before Altium announced Autodesk’s proposal, ALMFF’s closing price of AUD$27.21 was 41.5% above the proposal and 47.4% above the one-month volume-weighted average price.

    However, ALMFF rejected the bid, why?

    As its shares surged near six-month highs, Altium (ALMFF) rejected a $3.9 billion takeover bid saying it was too low but kept the option open for a higher offer. Despite the fact that analysts stated that the company was valued at 17 times forecast sales in 2022 or 44 times earnings forecasts, ALMFF rejected this approach. “ALMFF will evaluate all possible strategic alternatives” in conjunction with engaging with interested parties for an appropriate valuation.

  • How Has The RCMW Stock Appreciated 19% In The Last Session?

    RCMW Group Inc. (OTCPk: RCMW), a parent company to a vertically integrated group of business units that are emerging leaders in the consumer products category, closed Friday at $1.90, up 18.75 percent, and has been traded in a day range of $1.90 to $1.94. The RCMW stock has spiked over 40% in the last year with an average volume of over 19.99K shares. In the absence of current news, the RCMW stock rose, which allows us to point to recent developments to provide a better perspective on the stock.

    What’s new at RCMW?

    RCMW is a publicly-traded, vertically integrated company that operates and plans to diversify its portfolio of subsidiaries. Due to RCMW’s focus on assets, products, and ancillary offerings in consumer product-related industries, it is a well-positioned company to adapt quickly to market changes and capitalize on opportunities. A key focus of RCMW is to continuously identify opportunities and strategic acquisitions that will support the business model and help it stay at the forefront of the industry. RCMW currently operates in the Americas, Canada, Europe, and Asia.

    It has recently been announced that RCMW Group’s Pet Health Technology Inc., has signed a Purchase and Supply Agreement with Pet Valu Inc. for the supply of True Leaf Hemp Supplements and True Leaf Body and Oral Support products.

    As a leading pet specialty retailer, Pet Valu Inc. specializes in small-format pet products. With over 600 stores across Canada, Pet Valu operates under the brand names Pet Valu, Bosley’s by Pet Valu, Total Pet, and Tisol Pet Nutrition & Supply.

    Will RCMW subsidiary to benefit from this?

    RCMW subsidiary will have the opportunity to showcase its high-quality pet products throughout the Pet Valu family of retailers by virtue of this collaboration. The subsidiary of RCMW believes that Pet Valu will be able to market and sell the 19 sku they intend to stock through the 19-sku product line.

  • How Does The Taronis (TRNF) Stock Price Increase By 28%?

    On Friday, shares of the global producer of renewable and socially responsible fuel products,  Taronis Fuels Inc (OTCPink: TRNF) closed up 28.21 percent at $5.5000 and has been trading between $4.50 and $5.74. Taronis stock has gained 50.68% in the last month, with an average volume of almost 19 thousand shares. Following several announcements on Friday, TRNF stock rose.

    How did those developments occur?

    Global producer of renewable and environmentally friendly fuels, Tanoris is committed to a sustainable global economy. Providing safe solutions through TRNF is the key to meeting the future economic needs of the commercial, industrial, and residential sectors.

    A number of important developments were announced by Taronis on Friday, among them the appointment of Kevin Foti as CEO.

    • TRNF also announced that Wilbur Ross has joined the Company’s Board of Directors.
    • As part of the transaction, TRNF issued approximately $16.5 million of common stock to institutions and accredited investors in order to allow the company to reduce debt obligations while pursuing several key growth initiatives.
    • Investors received shares of TRNF’s common stock at a set price of $3.00, and warrants were not issued.
    • The TRNF’s transaction was exclusively placed by Kingswood Capital Markets, a division of Benchmark Investments, Inc. as its agent.

    TRNF moving forward:

    Nearly two months ago, TRNF put in place a new Board that remains dedicated to investors, employees, customers, and vendors. Taronis (TRNF) will continue to expand profitably as it makes its way to becoming one of the largest industrial gas companies.

  • Has SAML Stock Risen 44% Last Session For A Reason?

    Has SAML Stock Risen 44% Last Session For A Reason?

    Stock of Samsara Luggage Inc (OTCPk: SAML) jumped significantly as it reached $5.8600 at previous close, an increase of 43.98%. Compared to its monthly performance of 191.54%, Samsara Luggage stock has performed 106.34% over the last week. SAML’s stock rose as it expects dramatic sales growth in the upcoming year.

    How will SAML increase sales?

    Samsara is a global smart luggage and smart travel brand focused on making travel an effortless experience, rather than a hassle. With its innovative products, SAML transforms the travel industry by combining IoT technology, innovative design and quality materials. SAML created the Smart Weekender Nano Bag in response to the Coronavirus pandemic, an overnight travel bag treated with bacteriostatic nanotechnology that prevents bacteria from growing on the fabric.

    As recently reported by Authority Magazine, Samsara Luggage will use the launch of the Next Gen brand of luggage to continue boosting sales and preparing for an upcoming uplisting in the capital markets.

    • Recently, SAML announced that revenue for the first quarter of 2021 increased by 275% over last year.
    • A new generation of smart carry-on suitcases is expected to debut in the coming months as travel resumes.
    • Upon its unveiling at the 2020 Consumer Electronics Show (CES), the Next Gen was received with enthusiasm and anticipation.

    What is SAML’s role in making a difference?

    The next generation carry-on from Samsara Luggage (SAML) features WiFi Hotspot technology that gives travelers access to a global network during their travels. In addition to GPS tracking and Bluetooth 5.1, SAML’s Next Gen line also offers features such as USB-C charging and wireless charging port.

  • What Are The Reasons For The Increases In Nutriband (NTRB) Stock?

    What Are The Reasons For The Increases In Nutriband (NTRB) Stock?

    Nutriband Inc (OTCQB: NTRB), a Nevada Corporation, closed the last session at $14.990, gaining 24.92% and bringing its market cap to $95.28M. Nutriband stock has 25.00M shares outstanding and 0.54M float, according to the pink sheets company. Recently announced developments might provide us with more insight into the NTRB stock, as it was on an upbeat without current news.

    What has NTRB been up to recently?

    In its current capacity, Nutriband focuses on developing transdermal pharmaceutical products. NTRB is developing its abuse-deterrent fentanyl transdermal system for clinical use in managing chronic pain patients requiring opioid therapy as a first-of-its-kind drug that is not subject to abuse. With NTRB’s product, there is a unique method to prevent fentanyl patches from being abused and misused in order to combat the opioid crisis.

    Nutriband filed its audited financial reports on form 8-K/A this year with the SEC. Its reports covered both itself and its subsidiaries, along with pro forma financial statements for the NTRB and its subsidiaries. Pocono Coated Products LLC and Active Intelligence both are wholly owned subsidiaries of Nutriband.

    Other developments from NTRB:

    Nutriband (NTRB) also signed an exclusive licensing agreement with RAMBAM Med Tech Ltd, which operates as part of RAMBAM Hospital, northern Israel’s largest medical center. As per the agreements, NTRB is working with RAMBAM to develop a medical device dedicated to liquifying drugs for patients with swallowing difficulties.

  • How Did The Kalera (KSLLF) Stock Rise Nearly 41%?

    How Did The Kalera (KSLLF) Stock Rise Nearly 41%?

    Shares of Kalera AS (OTCPk: KSLLF), one of the fastest-growing US vertical farming companies in the world and a leader in plant science for producing high-quality produce in controlled environments, closed Friday’s session at $4.5000 after rising 40.63%, bringing the company’s market capitalization to $640.83. Kalera stock has traded between $1.8262 and $5.85. KSLLF stock rose despite the lack of current news, so recent developments can shed light on the stock.

    How is KSLLF doing these days?

    Kalera uses cutting-edge technology to cultivate plants using specially formulated light recipes, precise environmental controls, and sterile growing environments. By using these standards, KSLLF is able to produce non-GMO, pesticide-free, safe, and highly nutritious vegetables with predictable quality throughout the year. Hydroponic production facilities designed by KSLLF feature high yields, automated process data, reduction in cost, and limited environmental impact, with an industry-leading return on investment.

    Kalera recently celebrated its first harvest at its Atlanta facility.

    • KSLLF’s new facility is the largest vertical farm in the Southeastern United States and the largest farm they have ever operated.
    • With a production capacity of over 10 million heads of lettuce each year, KSLLF’s lettuce factory is 77 thousand square feet in size.
    • It has created dozens of jobs in the Atlanta area, thanks to the modular building method used by KSLLF to construct the farm in just eleven months.

    KSLLF – how will it excel?

    By optimizing their nutrient and light recipes, Kalera (KSLLF) is able to grow high-quality, pesticide-free, non-GMO produce at accelerated rates. Since its establishment in Atlanta, KSLLF has enjoyed optimal operating efficiencies, particularly in terms of lighting productivity.

  • How Did The IRME Stock Rocket In The Last Session, Jumping 25%?

    How Did The IRME Stock Rocket In The Last Session, Jumping 25%?

    IR-Med Inc. (OTCPINK: IRME) closed the last trading session at $14.990 after experiencing an increase of 24.92%, bringing its market capitalization to $95.28M. With 6.36M of outstanding shares, IR-Med stock traded 309 shares recently, less than its average daily volume of 689. Recent developments are useful for getting a better understanding of the IRME stock despite the lack of current news.

    What recent events took place at IRME?

    IR-Med is a company in the development stage that is handling the development and application of Artificial Intelligence (AI) and Infrared (IR) technologies. The technologies developed by IR-Med are initially designed to identify pressure injuries (PI) and ear infections early, especially in children.

    IR-Med announced that its Chief Executive Officer, Limor Davidson Mund, has resigned from the organization. A personal reason caused Ms. Davidson Mund to resign. Mr. Oded Bashan, Chairman of IRME, has been appointed the interim CEO.

    The company started the year by changing its name from International Display Advertising, Inc. to “IR-Med, Inc.”. In addition, the company’s ticker symbol was changed from “IDAD” to “IRME”. The corporate actions came into effect at the start of trading on January 20, 2021. Common stock now bears a CUSIP number of 46265R103.

    What impact does rebranding have on IRME?

    IRME announced, in December 2020, that a share exchange transaction with I.R Med Ltd., an Israeli company, had been completed, which resulted in I.R Med Ltd. becoming a wholly owned subsidiary of IRME. IR-Med (IRME) took these steps intentionally and strategically to rebrand itself. Under its new name, IRME is more closely aligned with its core business.

  • Do You Know Why Marizyme (MRZM) Stock Surged 52%?

    Do You Know Why Marizyme (MRZM) Stock Surged 52%?

    At the last close, Marizyme Inc [OTCQB: MRZM] was soaring 52.14 percent to $2.1300. Marizyme stock had a 52-week range of $1.0000 to $4.4800. MRZM stock rose without current news, so there may be some reasons to believe that recent developments will make Marizyme more attractive.

    How has MRZM been recently?

    A global life sciences company focused on acquiring, developing, and commercializing therapies that reduce mortality and costs in acute care settings, Marizyme offers integrated solutions for daily life. MRZM’s flagship product, DuraGraft, prevents endothelial damage whilst improving clinical outcomes by reducing complications associated with vein graft failure during bypass surgery. The use of DuraGraft significantly improves coronary artery bypass graft (CABG) surgical outcomes by decreasing adverse cardiac events like repeat revascularizations and myocardial infarctions.

    A recent letter to shareholders provided by Board Chairman James Sapirstein provides a status update on Marizyme’s recent activities. The full text of the Letter is available on the MRZM website.

    Key highlights of the letter:

    • MRZM In addition to pursuing new opportunities for DuraGraft sales in several European countries, MRZM is also working on getting DuraGraft cleared for sale in the U.S.
    • MRZM’s DuraGraft is currently approved in 33 countries across four continents.
    • As of now, MRZM has eight distributors covering eight countries, with more coming onto the payroll every month and several likely to sign agreements in the coming weeks.
    • Through its current distributor network, MRZM plans to increase DuraGraft sales within its present markets, which include EU, South America, Turkey, Chile, and Southeast Pacific.
    • A massive database of nearly 3,000 patients from our EU Registry study will be utilized to show DuraGraft’s value and outcomes in selected patient populations.

    MRZM’s plans go further:

    Marizyme (MRZM) is also negotiating with several partners to expand our commercial footprint in three Benelux countries and 18 countries across Central and Eastern Europe. MRZM is also working to expand into Mexico, Australia, New Zealand, the United Kingdom, the Irish Republic, France, as well as a new distributor in Italy.